Impact of new dialysis solutions on peritonitis rates

Kidney International

Volumn 70, Issue SUPPL. 103, 2006, Pages

  Ahmad, S ^a,b   Sehmi, J S ^a   Ahmad Zakhi, K H ^a   Clemenger, M ^a   Levy, J B ^a   Brown, E A ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Dialysis buffer; Dialysis solutions; Peritonitis

Indexed keywords

ANTIBIOTIC AGENT; BICARBONATE; CEFAZOLIN; DIALYSIS FLUID; DIANEAL; GENTAMICIN; LACTIC ACID; PERITONEAL DIALYSIS FLUID; PHYSIONEAL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CATHETER REMOVAL; CONTROLLED STUDY; DIALYSATE; DIALYSIS; HUMAN; INFECTION RATE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MORBIDITY; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; METHODOLOGY; PROSPECTIVE STUDY; RECURRENT DISEASE;

BICARBONATES; DIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; LACTIC ACID; PERITONEAL DIALYSIS; PERITONITIS; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 33750595607     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001917     Document Type: Article

References (26)

1. Davies SJ, Phillips L, Griffiths AM et al. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-2217.
2. Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-2957.
3. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498-506.
4. Margetts PJ, Churchill DN. Acquired ultrafiltration dysfunction in peritoneal dialysis patients. J Am Soc Nephrol 2002; 13: 2787-2794.
5. Liberek T, Topley N, Jorres A et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65: 260-265.
6. Witowski J, Korybalska K, Ksiazek K et al. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 2004; 19: 917-924.
7. Jones S, Holmes CJ, Mackenzie RK et al. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol 2002; 13(Suppl 1): S97-S103.
8. Mortier S, De Vriese AS, McLoughlin RM et al. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 2003; 14: 1296-1306.
9. Fusshoeller A, Plail M, Grabensee B, Plum J. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 2004; 19: 2101-2106.
10. Tranaeus A. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution-clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 2000; 20: 516-523.
11. Lee HY, Park HC, Seo BJ et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 2005; 25: 248-255.
12. Frajewicki V, Kushnir D, Wajsbrot V et al. Peritoneal transport after long-term exposure to Icodextrin in rats. Nephron 2002; 92: 174-182.
13. Shostak A, Pivnik K, Gotloib L. Daily short exposure of cultured mesothelial cells to lactated, high-glucose, low-pH peritoneal dialysis fluid induces a low-profile regenerative steady state. Nephrol Dial Transplant 1996; 11: 608-613.
14. Gotloib L, Waisbrut V, Shostak A, Kushnier R. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions. Nephron 1995; 70: 466-477.
15. Fusshoeller A, Baehr J, Grabensee B, Plum J. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Perit Dial Int 2005; 25: 387-393.
16. Bajo MA, del PG, Castro MA et al. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo. Adv Perit Dial 2001; 17: 37-41.
17. Jorres A, Bender TO, Finn A et al. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 1998; 54: 2184-2193.
18. Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells. Perit Dial Int 1994; 14(Suppl 3): S21-S28.
19. Jones S, Holmes CJ, Krediet RT et al. Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 2001; 59: 1529-1538.
20. Williams JD, Topley N, Craig KJ et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66: 408-418.
21. Garcia H, Hernandez-Jaras J, Cruz MC et al. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution. Perit Dial Int 2003; 23: 375-380.
22. Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63: 1404-1416.
23. Lee SK, Kim BS, Yang WS et al. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60: 55-64.
24. Topley N, Kaur D, Petersen MM et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49: 1447-1456.
25. Topley N, Kaur D, Petersen MM et al. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 1996; 7: 218-224.
26. Mastrosimone S, Virga G, Gastaldon F et al. Low peritonitis rate leads to high patient survival and technique success: the first five years of a peritoneal dialysis program. Perit Dial Int 2002; 22: 91-93.